Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02603991
Recruitment Status : Unknown
Verified October 2016 by Beijing Pins Medical Co., Ltd. Recruitment status was: Recruiting
Epileptic encephalopathy is very common in children and adolescent with epilepsy, but there is no data in clinical studies.The aim of this study is to evaluate the efficacy of the long-term vagus nerve stimulation for children and adolescent with epilepsy
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
4 Years to 18 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients at age 4-18; diagnostic criteria for epilepsia brain disorders; having tried appropriate anti-epileptic drugs (AEDs) more than 1 year and at least 6 seizures per month; patients or his(her) familys could understand this method and sign the informed consent; Patients with good compliance and could complete postoperative follow-up；without the vagus nerve lesion and damagement, progressive neurological diseases, cardiopulmonary anomaly, respiratory system diseases, digestive system diseases
Diagnostic criteria for epilepsia brain disorders
Having tried appropriate anti-epileptic drugs (AEDs) more than 1 year and zt least 6 seizures per month
patients or his(her) families could understand this method and sign the informed consent
Patients with good compliance and could complete postoperative follow-up
the vagus nerve lesion and damage
patients with progressive neurological diseases, cardiopulmonary anomaly, respiratory system diseases,digestive system diseases
patients'mental state is not stable，
patients with or anesthesia contraindications,such as long-term use of anticoagulation antiplatelet drugs etc.
patients have or need other implantable devices, such as pacemakers,defibrillators, cochlear and spinal nerve root stimulator.
patients due to their own reasons for the need for nuclear magnetic resonance imaging in the future clinical trials
patients have participated in other clinical trials.